Navigation Links
MicroAire and Arthrex Agree to Amicable Settlement on ECTR Patent
Date:11/9/2010

CHARLOTTESVILLE, Va., Nov. 9, 2010 /PRNewswire/ -- MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract.  At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.

Judge Norman K. Moon of the U.S. District Court for the Western District of Virginia approved the agreement on Thursday, October 28, without disclosing specific terms.  The two companies issued this joint statement expressing their commitment to the safety and efficacy of endoscopic carpal tunnel release, also known as ECTR.

As a result of the agreement, MicroAire will now license its patented ECTR technology to Arthrex for an undisclosed fee; and both companies will maintain MicroAire's practice of requiring surgeon training for this procedure.

Alan Connor, MicroAire's Vice President of Operations, expressed his satisfaction with the settlement, noting the emphasis on patient safety and surgeon training.  "MicroAire believes, as does Arthrex, that the endoscopic method of carpal tunnel release is a safe method that provides measurable patient benefits including a smaller scar, less pain and a faster recovery."

Anthony Cho, legal counsel for Arthrex, said, "Both Arthrex and MicroAire worked together in good faith to settle their differences amicably and should be commended for their efforts."

MicroAire's patented endoscopic treatment of carpal tunnel syndrome is a minimally invasive alternative to open-hand surgery.  Endoscopy enables visualization of the surgical procedure on a video monitor through the use of a tiny camera inserted into a small incision in the crease of the patient's wrist.  The treatment has been practiced for over twenty years and its safety and efficacy are supported by an impressive body of clinical data, including a randomized, prospective study involving more than 1,000 patients in 63 surgery centers.  (Agee, JM et al. "Endoscopic Release of the Carpal Tunnel: A Randomized Prospective Multicenter Study." Journal of Hand Surgery. 1992; 17(6):987-995)

MicroAire Surgical Instruments LLC, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas:  Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery.  MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes.  For more information, visit www.microaire.com.

Arthrex, headquartered in Naples, Florida, is a worldwide leader in sports medicine product development and educational services for orthopaedic surgeons.  Over 5,000 products for arthroscopic and minimally invasive orthopaedic surgical procedures have been developed by Arthrex and are currently marketed worldwide.  For more information, visit www.arthrex.com.Contact:D.J. Crotteau(434) 975-8389pr@microaire.com
'/>"/>

SOURCE MicroAire Surgical Instruments LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)
2. PLC Systems Signs TMR Asset Sale Agreement with Novadaq
3. Biotel, Inc. Announces Definitive Merger Agreement With CardioNet, Inc.
4. ThermoGenesis Signs Major Bone Marrow Product Distribution Agreement in China
5. Simbionix and AABIP Sign Collaboration Agreement
6. Tongjitang Chinese Medicines Enters into Merger Agreement with Tonsun International Company Limited, Hanmax Investment Limited and Fosun Industrial Co., Limited
7. Shield Therapeutics Signs Agreement With AOP Orphan for ST10-021
8. Covance and sanofi-aventis Finalize Agreements for 10-year Strategic R&D Alliance
9. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
10. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
11. Pilgrim Software and Portford Solutions Sign Strategic Reseller Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... R&D program in the use of cannabinoids for ... In June, 2015 InMed initiated its COPD program ... targets and potential active compounds that can be ... in vitro assays using human lung fibroblasts (HFL-1 ...
(Date:12/6/2016)... Dec. 6, 2016  In response to the tragic ... every 25 minutes, a respected group of local and ... provide a holistic suite of services to help Medicaid-eligible ... on his own experience trying to help family and ... Justin Lanning launched 180 Health Partners ...
(Date:12/5/2016)... YORK , Dec. 5, 2016  Balloon catheter ... catheter, which is inserted into the femoral artery in ... the arm to treat constricted blood vessels. These products ... due to atherosclerosis – deposition of lipid substances in ... balloon catheter market is projected to expand at a ...
Breaking Medicine Technology:
(Date:12/6/2016)... ... December 06, 2016 , ... The ... formally announce its Not a Moment to Lose fundraising campaign. As the V ... dedicated to declaring victory over cancer. The campaign aims to raise $200 million ...
(Date:12/6/2016)... Pittsburgh, PA (PRWEB) , ... December 06, 2016 ... ... particle identification and characterization laboratories, is now offering HIAC particle counting and sizing ... available immediately. , Gateway Analytical instituted the new service as a response to ...
(Date:12/6/2016)... Switzerland (PRWEB) , ... December 06, 2016 , ... ... a one-stop portal for all the knowledge resources, including white papers, guides, ... certificates, and more. , To access more than 9,000 documents, webinars and ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... the much-anticipated HydroFX for Water®. This first-of-its-kind water-soluble powder supplement has a ... world’s most powerful antioxidants, molecular hydrogen, HydroFX for Water transforms every day ...
(Date:12/6/2016)... ... ... Keeping Gift Season Safe, In a season stacked with gift-giving opportunities, it's ... recipients. This is the idea behind Safe Toys and Gifts Month, which sets aside ... good gifts for children. For companies that produce goods that fall into this category, ...
Breaking Medicine News(10 mins):